Identification of shared hub genes in lung cancer and rheumatoid arthritis patients using bioinformatics approaches

1 Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. Int J Molec Sci. 2021;22(16):10. DOI: 10.3390/ijms22168661 Search in Google Scholar

2 Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA oncol. 2021;7(12):1824-32. DOI: 10.1001/jamaoncol.2021.4932 Search in Google Scholar

3 Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023-38. DOI: 10.1016/S0140-6736(16)30173-8 Search in Google Scholar

4 Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020;9(4):10. DOI: 10.3390/cells9040880 Search in Google Scholar

5 Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert rev clin immunol. 2022;18(9):923-31. DOI: 10.1080/1744666X.2022.2106970 Search in Google Scholar

6 Rubbert-Roth A, Zander T, Kneitz C, Baerwald C, Wirtz H, Witt C. [Lung cancer and rheumatoid arthritis. An interdisciplinary challenge]. Zeitschrift fur Rheumatologie. 2016;75(1):47-53. DOI: 10.1007/s00393-016-0043-0 Search in Google Scholar

7 Wu X, Peng H, Wen Y, Cai X, Li C, Zhong R, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. Sem arthr rheum. 2021;51(3):565-75. DOI: 10.1016/j.semarthrit.2021.03.015 Search in Google Scholar

8 Fragoulis GE, Chatzidionysiou K. Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening? Clin rheum. 2020;39(3):957-61. DOI: 10.1007/s10067-019-04882-x Search in Google Scholar

9 Zhao W, Langfelder P, Fuller T, Dong J, Li A, Hovarth S. Weighted gene coexpression network analysis: state of the art. J Biopharm stat. 2010;20(2):281-300. DOI: 10.1080/10543400903572753 Search in Google Scholar

10 Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9:559. DOI: 10.1186/1471-2105-9-559 Search in Google Scholar

11 Rhoads A, Au KF. PacBio Sequencing and Its Applications. Genomics, proteomics & bioinformatics. 2015;13(5):278-89. DOI: 10.1016/j.gpb.2015.08.002 Search in Google Scholar

12 Zhang J, Li Y, Yang Y, Huang J, Sun Y, Zhang X, et al. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma. Cancer sci. 2023. DOI: 10.1111/cas.16015 Search in Google Scholar

13 Viktorsson K, Hååg P, Shah CH, Franzén B, Arapi V, Holmsten K, et al. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome. Molec oncol. 2022;16(20):3620-41. DOI: 10.1002/1878-0261.13288 Search in Google Scholar

14 Liu Y, Fan S, Meng S. Identification of the candidate genes of diagnosing rheumatoid arthritis using the single-cell sequencing technology and T cell subclusters analysis of patients with rheumatoid arthritis. Archiv rheumatol. 2023;38(1):109-18. DOI: 10.46497/ArchRheumatol.2022.9573 Search in Google Scholar

15 Zhu N, Yang Y, Wang H, Tang P, Zhang H, Sun H, et al. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma. Front Oncol. 2022;12:822849. DOI: 10.3389/fonc.2022.822849 Search in Google Scholar

16 Fan C, Hu H, Shen Y, Wang Q, Mao Y, Ye B, et al. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma. Translational oncol. 2021;14(4):101042. DOI: 10.1016/j.tranon.2021.101042 Search in Google Scholar

17 Zhao Z, Ren J, Xie S, Zou L, Zhao Q, Zeng S, et al. Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis. Front immunol. 2022;13:1044909. DOI: 10.3389/fimmu.2022.1044909 Search in Google Scholar

18 Mukherjee A, Epperly MW, Fisher R, Hou W, Shields D, Saiful Huq M, et al. Inhibition of tyrosine kinase Fgr prevents radiation-induced pulmonary fibrosis (RIPF). Cell death discovery. 2023;9(1):252. DOI: 10.1038/s41420-023-01538-3 Search in Google Scholar

19 Lu T, Xu R, Wang C, Zhou X, Parra-Medina R, Díaz-Peña R, et al. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma. J thoracic disease. 2023;15(7):3885-907. DOI: 10.21037/jtd-23-795 Search in Google Scholar

20 Schioppa T, Sozio F, Barbazza I, Scutera S, Bosisio D, Sozzani S, et al. Molecular Basis for CCRL2 Regulation of Leukocyte Migration. Front cell develop biol. 2020;8:615031. DOI: 10.3389/fcell.2020.615031 Search in Google Scholar

21 Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, et al. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance. Cancer immunol res. 2019;7(11):1775-88. DOI: 10.1158/2326-6066.CIR-19-0168 Search in Google Scholar

22 Sozio F, Schioppa T, Laffranchi M, Salvi V, Tamassia N, Bianchetto-Aguilera FM, et al. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer. Cancer immunol res. 2023;11(9):1280-95. DOI: 10.1158/2326-6066.CIR-22-0951 Search in Google Scholar

23 Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of Methotrexate Toxicity: A Comprehensive Literature Review. Cureus. 2022;14(9):e29518. DOI: 10.7759/cureus.29518 Search in Google Scholar

24 Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J med chem. 2018;158:502-16. DOI: 10.1016/j.ejmech.2018.09.027 Search in Google Scholar

25 Xie M, Chen X, Qin S, Bao Y, Bu K, Lu Y. Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia. J cancer res therap. 2018;14(1):226-32. DOI: 10.4103/0973-1482.188436 Search in Google Scholar

26 Dsouza NN, Alampady V, Baby K, Maity S, Byregowda BH, Nayak Y. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology. 2023;31(3):1167-82. DOI: 10.1007/s10787-023-01193-1 Search in Google Scholar